课题基金 / 基金详情

Big Data Methods for Comprehensive Similarity based Risk Prediction

Big Data Methods for Comprehensive Similarity based Risk Prediction
基于大数据的综合相似性风险预测方法
批准号:
10323033
负责人:
KRZYSZTOF KIRYLUK
金额:
$45.57万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-02-12 至 2024-01-31

项目摘要

项目成果

KRZYSZTOF KIRYLUK的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary Electronic health records (EHR) provide rich source of data about representative populations and are yet to be fully utilized to enhance clinical decision-making. Conventional approaches in clinical decision-making start with the identification of relevant biomarkers based on subject-matter knowledge, followed by detailed but limited analysis using these biomarkers exclusively. As the current scientific literature indicates, many human disorders share a complex etiological basis and exhibit correlated disease progression. Therefore, it is desirable to use comprehensive patient data for patient similarity. This proposal focuses on deriving a comprehensive and integrated score of patient similarity from complete patient characteristics currently available, including but not limited to 1) demographic similarity; 2) genetic similarity; 3) clinical phenotype similarity; 4) treatment similarity; and 5) exposome similarity (here exposome defined as all available attributes of the living environment an individual is exposed to), when some of the aspects may overlap and interact. We will optimize information fusion and task-dependent feature selection for assessing patient similarity for clinical risk prediction. Since currently there does not exist a pipeline that is able to extract executable complete patient determinant data, to achieve the research goal described above, we propose first deliver an open- source data preparation pipeline that is based on a widely used clinical data standard, the OMOP (Observational Medical Outcomes Partnership) Common Data Model (CMD) version 5.2. Moreover, to mitigate common missingness and sparsity challenges in clinical data, we describe the first attempt to represent patients' sparse clinical information with missingness, including diagnosis information, medication data, treatment intervention, with a fixed-length feature vector (i.e. the Patient2Vec). This project has four specific aims. Aim 1 is to develop a clinical data processing pipeline for harmonizing patient information from multiple sources into a standards-based uniformed data representation and to evaluate its efficiency, interoperability, and accuracy. Aim 2 is to leverage a powerful machine learning technique, Document2Vec, from the natural language processing literature, to create an open-source Patient2Vec framework for the derivation of informative numerical representations of patients. Aim 3 is to develop a unified machine learning clinical- outcome-prediction framework for Optimized Patient Similarity Fusion (OptPSF) that integrates traditional medical covariates with the derived numerical patient representations from Patient2Vec (Aim 2) for improved clinical risk prediction. Aim 4 is to evaluate our similarity framework for predicting 1) the risk of end-stage kidney disease (ESKD) in general EHR patient population and 2) the risk of death among patients with chronic kidney disease (CKD).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Non-APOL1 genetic factors and kidney transplant outcomes
Multi-Omics for Chronic Kidney Disease
MHC and KIR Sequencing and Association Analyses in the iGeneTRAiN Studies
  • 批准号:
    10438855
  • 项目类别:
  • 资助金额:
    $43.48万
  • 财政年份:
    2020
  • 负责人:
    KRZYSZTOF KIRYLUK
  • 依托单位:
MHC and KIR Sequencing and Association Analyses in the iGeneTRAiN Studies
  • 批准号:
    10251946
  • 项目类别:
  • 资助金额:
    $48.54万
  • 财政年份:
    2020
  • 负责人:
    KRZYSZTOF KIRYLUK
  • 依托单位:
海外基金